Showing results (121-130 of 279) with videos related to
Sort By:
Pageof 28
Haematologica|April 17, 2008
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting timeAdriana Balduzzi, Paola De Lorenzo, André Schrauder, et al.European Journal of Haematology|December 15, 2020
Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaManon Queudeville, Patrick Schlegel, Amadeus T Heinz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group ReportJanina Salzburg, Birgit Burkhardt, Martin Zimmermann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNSGunnar Cario, Shai Izraeli, Anja Teichert, et al.British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.Cancers|September 10, 2021
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic LeukemiaJonathan Lukas Lühmann, Marie Stelter, Marie Wolter, et al.Haematologica|August 6, 2013
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolGunnar Cario, Peter Rhein, Rita Mitlöhner, et al.Therapeutic Drug Monitoring|December 7, 2017
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 TrialClaudia Lanvers-Kaminsky, Andrea Rüffer, Gudrun Würthwein, et al.Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.Genes, Chromosomes & Cancer|March 6, 2003
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposidesThorsten Langer, Markus Metzler, Dirk Reinhardt, et al.Pageof 28